武汉友芝友生物制药股份有限公司（股票代码：02496）于2026年7月6日发布2026年6月股份变动月报表。报告期内，公司注册股本总额保持在人民币193,849,200元，其中H股179,479,113股（面值每股人民币1元）与内资股14,370,087股（面值每股人民币1元）维持不变，合计已发行股份数量无新增或回购注销情况。
公告显示，2024年6月27日公司曾采纳2024年H股购股权计划，截至2026年6月底，相关股份期权数量保持在1,250,000份，期间未因行使期权而新增发行股份或转让库藏股票。公司确认其公众持股量符合香港联交所相关上市规定。
公司强调，其持续严格遵守香港联交所《上市规则》及相关法律法规各项规定。本次公告由联席公司秘书郑建华签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.